Buprenorphine HCL Tablets Recalled for Potential Label Mixup
Aidapak Services, LLC is recalling Buprenorphine HCL SL tablets due to a potential label mixup with other medications.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score according to the rubric, as it involves a labeling error that could lead to serious adverse health consequences.
Plain-English summary
Aidapak Services, LLC is recalling Buprenorphine HCL SL, Tablet, 2 mg (NDC 00054017613) because the product may be potentially mislabeled as Docusate Sodium, Capsule, 250 mg or Magnesium Chloride DR, Tablet, 64 mg. The recall is classified as FDA Class II.
The affected repacked drugs were distributed in Arizona, California, Oregon, and Washington. The specific lots involved include Pedigree AD39573_1 with an expiration date of 5/13/2014 and Pedigree AD54478_1 with an expiration date of 5/20/2014.
Consumers should check their medication labels and consult their healthcare provider or pharmacist if they have questions regarding this recall.
The recalled product
- Product
- BUPRENORPHINE HCL SL, Tablet, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054017613.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 60
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- BUPRENORPHINE HCL SL
- Tablet
- 2 mg has the following codes: Pedigree: AD39573_1
- EXP: 5/13/2014
- Pedigree: AD54478_1
- EXP: 5/20/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02